Vtesse
Latest round
- Series A
Last raised
- Mar 2016
Total raised
- $39M
Investors
- 5
About Vtesse
Vtesse, Inc.Vtesse, Inc. specializes in addressing rare metabolic diseases with targeted therapies. The company was acquired on April 3, 2017, by Sucampo Pharmaceuticals, Inc. Vtesse's headquarters is located in Gaithersburg, US.Vtesse, Inc. develops and commercializes pharmaceutical products aimed at treating rare metabolic disorders.Vtesse, Inc. generates revenue through strategic partnerships and direct sales to healthcare providers and institutions.Vtesse, Inc. The company aims to enhance its market presence in the US and is exploring opportunities in Europe and Asia by 2020.
Who invested in Vtesse
5 investors across 3 rounds
See all investors in Vtesse
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vtesse
Who invested in Vtesse?
Vtesse has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vtesse raised?
Vtesse has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Vtesse last raise money?
Vtesse's most recent round on record is a Series A, in Mar 2016.
What does Vtesse do?
Vtesse is a pharmaceuticals company.
Where is Vtesse headquartered?
Vtesse is headquartered in Gaithersburg, US.
Which VCs invest in companies like Vtesse?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Vtesse's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Vtesse? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.